These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38306043)

  • 1. Disentangling Accelerated Cognitive Decline from the Normal Aging Process and Unraveling Its Genetic Components: A Neuroimaging-Based Deep Learning Approach.
    Dai Y; Hsu YC; Fernandes BS; Zhang K; Li X; Enduru N; Liu A; Manuel AM; Jiang X; Zhao Z;
    J Alzheimers Dis; 2024; 97(4):1807-1827. PubMed ID: 38306043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disentangling accelerated cognitive decline from the normal aging process and unraveling its genetic components: A neuroimaging-based deep learning approach.
    Dai Y; Yu-Chun H; Fernandes BS; Zhang K; Xiaoyang L; Enduru N; Liu A; Manuel AM; Jiang X; Zhao Z
    Res Sq; 2023 Sep; ():. PubMed ID: 37720047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease.
    Giorgio J; Landau SM; Jagust WJ; Tino P; Kourtzi Z;
    Neuroimage Clin; 2020; 26():102199. PubMed ID: 32106025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep learning-based identification of genetic variants: application to Alzheimer's disease classification.
    Jo T; Nho K; Bice P; Saykin AJ;
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35183061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine learning framework for early MRI-based Alzheimer's conversion prediction in MCI subjects.
    Moradi E; Pepe A; Gaser C; Huttunen H; Tohka J;
    Neuroimage; 2015 Jan; 104():398-412. PubMed ID: 25312773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglial activation and tau burden predict cognitive decline in Alzheimer's disease.
    Malpetti M; Kievit RA; Passamonti L; Jones PS; Tsvetanov KA; Rittman T; Mak E; Nicastro N; Bevan-Jones WR; Su L; Hong YT; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2020 May; 143(5):1588-1602. PubMed ID: 32380523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study.
    Millar PR; Gordon BA; Luckett PH; Benzinger TLS; Cruchaga C; Fagan AM; Hassenstab JJ; Perrin RJ; Schindler SE; Allegri RF; Day GS; Farlow MR; Mori H; Nübling G; ; Bateman RJ; Morris JC; Ances BM
    Elife; 2023 Jan; 12():. PubMed ID: 36607335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Deep-Learning Genomics to Discriminate Healthy Individuals from Those with Alzheimer's Disease or Mild Cognitive Impairment.
    Li L; Yang Y; Zhang Q; Wang J; Jiang J; Neuroimaging Initiative AD
    Behav Neurol; 2021; 2021():3359103. PubMed ID: 34336000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing a pre-defined versus deep learning approach for extracting brain atrophy patterns to predict cognitive decline due to Alzheimer's disease in patients with mild cognitive symptoms.
    Arvidsson I; Strandberg O; Palmqvist S; Stomrud E; Cullen N; Janelidze S; Tideman P; Heyden A; Åström K; Hansson O; Mattsson-Carlgren N
    Alzheimers Res Ther; 2024 Mar; 16(1):61. PubMed ID: 38504336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving Alzheimer Diagnoses With An Interpretable Deep Learning Framework: Including Neuropsychiatric Symptoms.
    Liu S; Zheng Y; Li H; Pan M; Fang Z; Liu M; Qiao Y; Pan N; Jia W; Ge X
    Neuroscience; 2023 Nov; 531():86-98. PubMed ID: 37709003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal MRI analysis using a hybrid DenseNet-BiLSTM method for Alzheimer's disease prediction.
    Jomeiri A; Navin AH; Shamsi M
    Behav Brain Res; 2024 Apr; 463():114900. PubMed ID: 38341100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-driven domain generalization for neuroimaging-based assessment of Alzheimer's disease.
    Lteif D; Sreerama S; Bargal SA; Plummer BA; Au R; Kolachalama VB
    Hum Brain Mapp; 2024 Jun; 45(8):e26707. PubMed ID: 38798082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Diadem: a constrained dual-input deep learning model to identify novel biomarkers in Alzheimer's disease.
    Jemimah S; AlShehhi A;
    BMC Med Genomics; 2023 Oct; 16(Suppl 2):244. PubMed ID: 37833700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using high-dimensional machine learning methods to estimate an anatomical risk factor for Alzheimer's disease across imaging databases.
    Casanova R; Barnard RT; Gaussoin SA; Saldana S; Hayden KM; Manson JE; Wallace RB; Rapp SR; Resnick SM; Espeland MA; Chen JC;
    Neuroimage; 2018 Dec; 183():401-411. PubMed ID: 30130645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Earlier Biomarkers for Alzheimer's Disease: A Multimodal Neuroimaging Study of Individuals with Subjective Cognitive Decline.
    Parker AF; Smart CM; Scarapicchia V; Gawryluk JR;
    J Alzheimers Dis; 2020; 77(3):1067-1076. PubMed ID: 32804127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging genomics discovery of a new risk variant for Alzheimer's disease in the postsynaptic SHARPIN gene.
    Soheili-Nezhad S; Jahanshad N; Guelfi S; Khosrowabadi R; Saykin AJ; Thompson PM; Beckmann CF; Sprooten E; Zarei M;
    Hum Brain Mapp; 2020 Sep; 41(13):3737-3748. PubMed ID: 32558014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep Learning-Based Feature Extraction with MRI Data in Neuroimaging Genetics for Alzheimer's Disease.
    Chakraborty D; Zhuang Z; Xue H; Fiecas MB; Shen X; Pan W;
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation and neuroimaging measures in Alzheimer disease.
    Biffi A; Anderson CD; Desikan RS; Sabuncu M; Cortellini L; Schmansky N; Salat D; Rosand J;
    Arch Neurol; 2010 Jun; 67(6):677-85. PubMed ID: 20558387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.